icon-    folder.gif   Conference Reports for NATAP  
  19th Conference on Retroviruses and
Opportunistic Infections
Seattle, WA March 5 - 8, 2012
Back grey_arrow_rt.gif
Augmentation of Interferon signaling pathway by Nitazoxanide: A therapeutic strategy for HIV/HCV Coinfected Relapsers to Peg-interferon and Ribavirin therapy.
  Reported by Jules Levin
CROI 2012 March 5-8 Seattle WA
1,2Osinusi A, 1Wang C, 1Zhang X, 1Shivabesan G, 1Shivakumar B, 2Silk R, 3Doonquah, L, 4Henn S, 5Teferi, G, 6Masur H, 1Kottilil S, 2Fishbein D1LIR,NIAID, NIH, Bethesda, MD, 2 Clinical Research Directorate/CMRP, SAIC-Frederick, NCI-Frederick, Frederick, MD, 3Family & Medical Counseling Service, Washington DC,4Whitman Walker Clinic, Washington DC, 5Unity Healthcare, Inc, Washington DC, 6CCMD, CC, NIH, Bethesda, MD.